705 related articles for article (PubMed ID: 19686413)
1. Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis.
Zhang D; Hao J; Yang N
J Gastroenterol Hepatol; 2010 Jan; 25(1):116-21. PubMed ID: 19686413
[TBL] [Abstract][Full Text] [Related]
2. Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism.
Kawanaka H; Akahoshi T; Kinjo N; Konishi K; Yoshida D; Anegawa G; Yamaguchi S; Uehara H; Hashimoto N; Tsutsumi N; Tomikawa M; Maehara Y
Ann Surg; 2010 Jan; 251(1):76-83. PubMed ID: 19864937
[TBL] [Abstract][Full Text] [Related]
3. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development.
Zocco MA; Di Stasio E; De Cristofaro R; Novi M; Ainora ME; Ponziani F; Riccardi L; Lancellotti S; Santoliquido A; Flore R; Pompili M; Rapaccini GL; Tondi P; Gasbarrini GB; Landolfi R; Gasbarrini A
J Hepatol; 2009 Oct; 51(4):682-9. PubMed ID: 19464747
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis.
Amitrano L; Guardascione MA; Brancaccio V; Margaglione M; Manguso F; Iannaccone L; Grandone E; Balzano A
J Hepatol; 2004 May; 40(5):736-41. PubMed ID: 15094219
[TBL] [Abstract][Full Text] [Related]
5. Coagulopathy in liver disease: the whole is greater than the sum of its parts.
Hodge A; Crispin P
J Gastroenterol Hepatol; 2010 Jan; 25(1):1-2. PubMed ID: 20136967
[No Abstract] [Full Text] [Related]
6. Analysis of coagulation parameters in the early period after kidney transplantation.
Pawlicki J; Cierpka L; Król R; Ziaja J
Transplant Proc; 2007 Nov; 39(9):2754-5. PubMed ID: 18021978
[TBL] [Abstract][Full Text] [Related]
7. [The relationship between hemostatic changes in liver cirrhosis patients with different degrees of liver lesions in reference to Child-Pugh scores].
Cong YL; Wei YX; Zhang LW; Yin ZJ; Bai J
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):31-4. PubMed ID: 15670488
[TBL] [Abstract][Full Text] [Related]
8. Coagulation imbalance may not contribute to the development of portal vein thrombosis in patients with cirrhosis.
Chen H; Qi X; He C; Yin Z; Fan D; Han G
Thromb Res; 2013 Feb; 131(2):173-7. PubMed ID: 23157737
[TBL] [Abstract][Full Text] [Related]
9. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
Kahn SR; Solymoss S; Flegel KM
CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
[TBL] [Abstract][Full Text] [Related]
10. [Changes in levels of blood coagulation inhibitors in cirrhosis. Prospective study in 33 patients].
Dumontier I; Alhenc-Gelas M; Chatellier G; Brenet P; Aiach M; Petite JP
Gastroenterol Clin Biol; 1992; 16(2):120-5. PubMed ID: 1314744
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of D-dimer and factor VIII in cirrhotic patients with asymptomatic portal venous thrombosis.
Fimognari FL; De Santis A; Piccheri C; Moscatelli R; Gigliotti F; Vestri A; Attili A; Violi F
J Lab Clin Med; 2005 Oct; 146(4):238-43. PubMed ID: 16194685
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma prothrombin concentration in cirrhotic patients with portal vein thrombosis and prothrombin G20210A mutation.
Amitrano L; Guardascione MA; Ames PR; Margaglione M; Iannaccone L; Brancaccio V; Balzano A
Thromb Haemost; 2006 Feb; 95(2):221-3. PubMed ID: 16493481
[TBL] [Abstract][Full Text] [Related]
13. High-D-dimer plasma levels predict poor outcome in esophageal variceal bleeding.
Primignani M; Dell'Era A; Bucciarelli P; Bottasso B; Bajetta MT; de Franchis R; Cattaneo M
Dig Liver Dis; 2008 Nov; 40(11):874-81. PubMed ID: 18329968
[TBL] [Abstract][Full Text] [Related]
14. Portal vein thrombosis after splenectomy in pediatric hematologic disease: risk factors, clinical features, and outcome.
Soyer T; Ciftci AO; Tanyel FC; Senocak ME; Büyükpamukçu N
J Pediatr Surg; 2006 Nov; 41(11):1899-902. PubMed ID: 17101367
[TBL] [Abstract][Full Text] [Related]
15. Study of portal vein thrombosis in patients with idiopathic portal hypertension in Japan.
Matsutani S; Maruyama H; Akiike T; Kobayashi S; Yoshizumi H; Okugawa H; Fukuzawa T; Kimura K; Saisho H
Liver Int; 2005 Oct; 25(5):978-83. PubMed ID: 16162156
[TBL] [Abstract][Full Text] [Related]
16. Importance of anticoagulant proteins in chronic liver diseases.
Gürsoy S; Başkol M; Torun E; Yurci A; Soyuer I; Eser B; Güven K; Ozbakir O; Yücesoy M
Turk J Gastroenterol; 2005 Sep; 16(3):129-33. PubMed ID: 16245221
[TBL] [Abstract][Full Text] [Related]
17. Hypercoagulability in patients with chronic noncirrhotic portal vein thrombosis.
Raffa S; Reverter JC; Seijo S; Tassies D; Abraldes JG; Bosch J; García-Pagán JC
Clin Gastroenterol Hepatol; 2012 Jan; 10(1):72-8. PubMed ID: 21946303
[TBL] [Abstract][Full Text] [Related]
18. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
19. [Clinical features of liver cirrhosis complicated by portal vein thrombosis and related risk factors].
Lin GS; Xu Q; Zhao SY; Zhang YX
Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):513-517. PubMed ID: 27784429
[No Abstract] [Full Text] [Related]
20. Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis.
Violi F; Ferro D; Basili S; Quintarelli C; Musca A; Cordova C; Balsano F
Hepatology; 1993 Jan; 17(1):78-83. PubMed ID: 8423044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
